Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 32Ovarian Neoplasms 21Neoplasms 14Carcinoma, Hepatocellular 13Fallopian Tube Neoplasms 12Carcinoma, Non-Small-Cell Lung 9Endometrial Neoplasms 7Colonic Neoplasms 7Neoplasm Metastasis 6Squamous Cell Carcinoma of Head and Neck 4Glioblastoma 4Breast Neoplasms 4Brain Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Lung Neoplasms 3Liver Neoplasms 3Biliary Tract Neoplasms 3Sarcoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2Neuroma, Acoustic 2Neurofibromatosis 2 2Mouth Neoplasms 2Meningioma 2Lymphoid Interstitial Pneumonia 2Gastrointestinal Neoplasms 2Digestive System Neoplasms 2

Interventions

pembrolizumab 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1Cisplatin 1Cetuximab 1Carboplatin 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Bevacizumab × 30 days × Clear all
NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡